Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
3.140
-0.240 (-7.10%)
Jun 25, 2026, 4:00 PM EDT - Market closed
Evaxion Market Cap
Evaxion has a market cap or net worth of $26.19 million as of June 25, 2026. Its market cap has increased by 37.28% in one year.
Market Cap
26.19M
Enterprise Value
7.75M
1-Year Change
37.28%
Ranking
Category
Stock Price
$3.14
Market Cap Chart
Since the IPO on February 5, 2021, Evaxion's market cap has decreased from $191.99M to $26.19M, a decrease of -86.36%. That is a compound annual growth rate of -30.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 26.19M | -34.17% |
| Dec 31, 2025 | 39.78M | 702.21% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CervoMed | 30.18M |
| Lite Strategy | 29.70M |
| GridAI Technologies | 29.41M |
| Kyntra Bio | 28.13M |
| Serina Therapeutics | 27.60M |
| Vistagen Therapeutics | 27.28M |
| Plus Therapeutics | 27.26M |
| Barinthus Biotherapeutics | 26.96M |